Dengue and chikungunya infections in travelers

Current Opinion in Infectious Diseases

Volumn 23, Issue 5, 2010, Pages 438-444

  Chen, Lin H ^a,b   Wilson, Mary E ^a,b,c  

^a MOUNT AUBURN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

alphavirus; chikungunya; dengue; flavivirus; travelers

Indexed keywords

CARBODINE; CHLOROQUINE; CORTICOSTEROID; DENGUE VACCINE; INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; QUININE; RIBAVIRIN;

AEDES ALBOPICTUS; BRAZIL; CHIKUNGUNYA ALPHAVIRUS; DENGUE; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INDIAN OCEAN; INFECTION CONTROL; INFECTION PREVENTION; ITALY; REVIEW; SOUTH ASIA; SOUTHEAST ASIA; TRAVEL; VIRUS INFECTION; VIRUS MUTATION; VIRUS SURVIVAL; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AEDES; ALPHAVIRUS INFECTIONS; AMERICAS; ANIMALS; ASIA; CHIKUNGUNYA VIRUS; DENGUE; DENGUE VIRUS; DISEASE VECTORS; HUMANS; INCIDENCE; ITALY; TRAVEL; VIRULENCE;

EID: 77956230553     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833c1d16     Document Type: Review

References (54)

1. Wilson ME, Freedman DO. Etiology of travel-related fever. Curr Opin Infect Dis 2007; 20:449-453.
2. Wilson ME, Weld LH, Boggild A, etal. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44:1560-1568.
3. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119-130.
4. Chen LH, Wilson ME. Transmission of dengue without a mosquito vector: nosocomial mucocutaneous transmission and other routes of dengue transmission. Clin Infect Dis 2004; 39:e56-e60.
5. Chen LH, Wilson ME. Nosocomial dengue by mucocutaneous transmission. Emerg Infect Dis 2005; 11:775.
6. WHO. Dengue: guidelines for diagnosis, treatment, prevention, and control. WHO/HTM/NTD/DEN/2009. Geneva: World Health Organization. http://whqlibdoc.who.int/publications/2009/9789241547871-eng.pdf. [Accessed 1 December 2009]
7. Chadee DD, Martinez R. Landing periodicity of Aedes aegypti with implications for dengue transmission in Trinidad, West Indies. J Vector Ecol 2000; 25:158-163.
8. Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis 2003; 3:463-464.
9. Enserink M. Entomology. A mosquito goes global. Science 2008; 320:864-866.
10. Tatem AJ, Hay SI, Rogers DJ. Global traffic and disease vector dispersal. Proc Natl Acad Sci USA 2006; 103:6242-6247.
11. Reiskind MH, Pesko K, Westbrook CJ, Mores CN. Susceptibility of Florida mosquitoes to infection with chikungunya virus. Am J Trop Med Hyg 2008; 78:422-425.
12. Vazeille M, Jeannin C, Martin E, et al. Chikungunya: a risk for Mediterranean countries. Acta Trop 2008; 105:200-202.
13. Gould EA, Coutard B, Malet H, etal. Understanding the alphaviruses: Recent research on important emerging pathogens and progress towards their control. Antiviral Res 2009. doi: 10.1016/j.antiviral.2009.07.007 [Epub ahead of print].
14. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006; 3:e263.
15. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007;3:e201.
16. Cardosa J, Ooi MH, Tio PH, et al. Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever. PLoS NTD 2009; 3:e423.
17. Martin JLS, BrathwaiteOB, Zambrano B, et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010; 82:128-135.
18. Teixeira MG, Costa MDCN, Barreto F, Barreto ML. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica, Rio De Janeiro 2009; 25 (Suppl. 1):S7-S18.
19. WHO. WHO report on global surveillance of epidemic-prone infectious diseases-Dengue and dengue haemorrhagic fever. http://www.who.int/csr/resources/ publications/dengue/CSR-ISR-2000-1/en/index5.html. [Accessed 1 April 2010]
20. Kuno G. Review of the factors modulating dengue transmission. Epidemiol Rev 1995; 17:321-335.
21. Ubol S, Phuklia W, Kalayanarooj S, Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 2010; 201:923-935.
22. Gregory CJ, Santiago LM, Arguello DF, et al. Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area-Puerto Rico, 2007-2008. Am J Trop Med Hyg 2010; 82:922-929.
23. Schwartz E, Weld LH, Wilder-Smith A, etal. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis 2008; 14:1081-1088.
24. Cobelens JG, Groen J, Osterhaus AD, et al. Incidence and risk factors of probable dengue virus infection among Dutch travelers to Asia. Trop Med Int Health 2002; 7:331-338.
25. Potasman I, Srugo I, Schwartz E. Dengue serovonversion among Israeli travelers to tropical countries. Emerg Infect Dis 1999; 5:824-827.
26. Sanchez-Vegas C, Hamer D, Chen LH, etal. Dengue virus seroprevalence in travelers attending travel clinics in the Boston area. Abstracts of the 11th Conference of the International Society of Travel Medicine (ISTM), Budapest, Hungary, May, 2009; FC03.03;71.
27. Capeding RZ, Gibbons RV, Jarman RG, etal. The incidence, characteristics, and presentation of dengue virus infections during infancy. Am J Trop Med Hyg 2010; 82:330-336.
28. Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am 2008; 92:1323-1343.
29. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009; 49:942-948.
30. Sergon K, Njuguna C, Kalani R, et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 2008; 78:333-337.
31. Soumahoro M-K, Fontenille D, Tuberlin C, et al. Imported chikungunya virus infection [letter]. Emerg Infect Dis 2010; 16:162-163.
32. Hochedez P, Jaureguiberry S, Debruyne M, etal. Chikungunya infection in travelers. Emerg Infect Dis 2006; 12:1565-1567.
33. Parola P, De Lamballerie X, Jourdan J, etal. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 2006; 12:1493-1499.
34. Taubitz W, Cramer JP, Kapaun A, etal. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis 2007; 45:e1-e4.
35. Rezza G, Nicoletti L, Angelini R, et al., CHIKV Study Group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370:1840-1846.
36. Charrel RN, De Lamballerie X, Raoult D. Chikungunya outbreaks-the globalization of vectorborne diseases. N Engl J Med 2007; 356:769-771.
37. ECDC Technical Report. Development of Aedes albopictus risk maps. Stokholm, May 2009. Available from http://ecdc.europa.eu/en/activities/pages/ programme-on-emerging-and-vector-borne-diseases-maps.aspx. [Accessed 5 April 2010]
38. Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007; 44:1401-1407.
39. Renault P, Josseran L, Pierre V. Chikungunya-related fatality rates, Mauritius, India, and Reunion Island. Emerg Infect Dis 2008; 14:1327.
40. Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 2008; 47:469-475.
41. Sissoko D, Malvy D, Ezzedine K, etal. Postepidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 2009; 3:e389.
42. Rajapakse S, Rodrigo C, Rajapakse A. Atypical manifestations of chikungunya infection. Trans R Soc Trop Med Hyg 2010; 104:89-96.
43. Simon F, Parola P, Grandadam M, etal. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 2007; 86:123-137.
44. Larrieu S, Pouderoux N, Pistone T, etal. Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 2010; 47:85-88.
45. Oliver M, Grandadam M, Marimoutou C, et al. Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis 2009; 3:e374.
46. Couderc T, Khandoudi N, Grandadam M, et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 2009; 200:516-523.
47. Lanciotti RS, Kosoy OL, Laven JJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007; 13:764-767.
48. Petersen LR, Stramer SL, Powers AM. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010; 24:15-21.
49. Ng LC, Tan LK, Tan CH, et al. Entomologic and virologic investigation of Chikungunya, Singapore. Emerg Infect Dis 2009; 15:1243-1249.
50. Massad E, Wilder-Smith A. Risk estimates of dengue in travelers to dengue endemic areas using mathematical models. J Travel Med 2009; 16:191-193.
51. Massad E, MaS, Burattini MN, etal. The risk of chikungunya fever in a dengue-endemic area. J Travel Med 2008; 15:147-155.
52. Chahar HS, Bharaj P, Dar L, et al. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis 2009; 15:1077-1080.
53. Leroy EM, Nkoghe D, Ollomo B, et al. Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, 2007. Emerg Infect Dis 2009; 15:591-593.
54. Schilling S, Emmerich P, Gunther S, Schmidt-Chanasit J. Dengue and Chikungunya virus co-infection in a German traveller. J Clin Virol 2009; 45:163-164.